Founded in 2013 by Christian Girard, a biopharma and consulting veteran, Christian Girard EIRL, d/b/a Orphan Drugs Industry Advisory & Intelligence, is a boutique strategic consulting practice, with a unique focus: the rare diseases arena. Several C-level executives joined him since expanding our capabilities and expertise.
We assist early-stage biotech companies as well as leading biopharmas executives in operations, deal-making, fund-raising, and mergers & acquisitions. From recommendation to execution.
Therapeutic areas of interest
- Inborn Errors of Metabolism
- Neuromuscular disorders
- Rare oncology
Feel free to contact us for more information.